GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Artificial Intelligence /LLMs Rapidly Transform European Gastroenterology Practice : Gut | June 2026

LLMs Rapidly Transform European Gastroenterology Practice : Gut | June 2026

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated June 1, 2026

Quick Answer

Introduction: Large language models (LLMs), exemplified by ChatGPT and similar artificial intelligence platforms, are rapidly reshaping healthcare delivery, medical education, and scientific research. In gastroenterology, these technologies have the potential to support clinical decision-making, streamline documentation, enhance endoscopy workflows, and improve academic productivity.


Introduction:

Large language models (LLMs), exemplified by ChatGPT and similar artificial intelligence platforms, are rapidly reshaping healthcare delivery, medical education, and scientific research. In gastroenterology, these technologies have the potential to support clinical decision-making, streamline documentation, enhance endoscopy workflows, and improve academic productivity. Despite their growing visibility, real-world data on how gastroenterologists are using LLMs in daily practice have been limited.

Problem Statement:

The widespread adoption of LLMs has occurred faster than the development of formal training programs, governance frameworks, and specialty-specific guidance. Understanding current patterns of use, perceived benefits, concerns, and barriers is essential for ensuring safe and effective integration of these technologies into gastroenterology practice.

Summary:

The EuroGI-AI project provides the largest assessment to date of LLM adoption among European gastroenterologists. The survey demonstrated that more than half of respondents already use LLMs in their clinical or academic activities, with many engaging with these tools on a weekly or daily basis. Educational purposes, clinical decision support, and scientific writing emerged as the most common applications. Among academic users, literature summarization and language refinement were particularly valued, highlighting the growing role of AI in research productivity. Most respondents considered LLMs reliable and believed they improve professional efficiency and clinical outcomes. Notably, many clinicians also recognized potential applications within endoscopy practice. However, concerns regarding inaccuracies remained common and were associated with reduced trust in AI-generated outputs. Despite widespread use, formal training was uncommon, yet there was overwhelming support for structured educational programs and incorporation of AI competencies into gastroenterology curricula. Institutional restrictions, financial costs, technological complexity, and time limitations were identified as key barriers to broader adoption. Overall, the findings suggest that LLMs are rapidly becoming integrated into European gastroenterology practice. Future success will depend on specialty-specific development, structured training, robust governance frameworks, and ongoing evaluation to ensure safe, ethical, and clinically meaningful implementation of AI technologies.

Related Q&A

AI and U.S. Healthcare Costs: NEJM Catalyst | July 2026

Introduction: Artificial intelligence is rapidly transforming healthcare through drug discovery, clinical decision support, remote monitoring, and administrative automation. While AI is widely expected to reduce healthcare costs, this perspective argues that current payment models and...

Large AI Models and Healthcare: Nature Medicine | June 2026

Introduction: Large frontier AI models such as GPT-5 and Gemini have achieved impressive results across numerous healthcare benchmarks. However, high benchmark scores alone may not reflect real-world clinical reliability. This study systematically evaluated the robustness...

AI Ethics From Silicon Valley to the Vatican: JAMA | July 2026

Introduction: Artificial intelligence is rapidly transforming medicine, but its influence extends far beyond healthcare. This JAMA AI Conversations article explores how AI ethics has become a global societal issue, engaging technology leaders, policymakers, healthcare professionals,...

Physician-Complementing AI in Oncology: The ASCO Post | June 2026

Introduction: Artificial intelligence is rapidly transforming oncology, evolving from image interpretation and pathology analysis to supporting complex clinical decision-making. This perspective argues that AI should enhance the capabilities of oncologists rather than replace their expertise....

AI-Based Clinical Trial End Points: A New Era in Drug Development: NEJM AI | July 2026

Introduction Clinical trial endpoints have traditionally relied on expert human interpretation, particularly for pathology-based outcomes. However, variability between observers, cost, and time remain important limitations. This NEJM AI perspective discusses how artificial intelligence is beginning...

Medical AI Assistant: Publication or Medical Device?: NEJM AI | July 2026

Introduction: As artificial intelligence becomes increasingly integrated into clinical practice, an important question arises: should AI assistants be regulated as medical devices or viewed as evidence-based clinical methodologies? This NEJM AI perspective proposes a new...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer